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ess: peterf@ichr.uwa.eSummary The collection of exhaled breath condensate (EBC) is simple and non-
invasive, however, there are few data on the methodological aspects affecting
concentrations of compounds in EBC. The aim of this study was to investigate
methodological issues for measuring nitric oxide metabolites (NOx) in EBC.
Twenty-five healthy adults (12 females, age range 23–55 years) and 22 children
(11 females, age range 7–6 years) were recruited for studies investigating inter- and
intra-day repeatability, repeatability with controlled expiratory flows and tempera-
ture, flow dependence, and analytical variability of EBC NOx.
Both intra- and inter-day repeatability was poor with a coefficient of
repeatability of 103.4% of the mean difference between intra-day (15min) measures
and 118.6% of inter-day (24 h) differences. Repeatability was not improved when
expiratory flow and temperature of the collection device were controlled. However,
some of the variability (approximately 50%) may be accounted for by variability in
the analytical technique (analytical variability) and this may result from difficulties
in controlling for contamination. NOx levels were not affected by different
expiratory flows in either adults or children but there was still significant variation
within individuals.Elsevier Ltd. All rights reserved.
340 8176; fax: +61 8 9388 2097.
du.au (P. Franklin).
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EBC NOx is to be used in clinical studies.
& 2005 Elsevier Ltd. All rights reserved.Introduction
The measurement of constituents of exhaled
breath condensates (EBC) is a potential non-
invasive method for monitoring patho-physiologic
processes in the airways.1 This is a growing area of
research and a large number of volatile and non-
volatile compounds have been measured. Included
among these are the metabolites of nitric oxide
(NOx), such as nitrite, nitrate, nitrotyrosine and
nitrosothiols. Nitric oxide metabolites in EBC have
been found to be elevated in patients with
inflammatory airways diseases such as asthma,2–4
cystic fibrosis2,3,5–8 and chronic obstructive pul-
monary disease.2
The collection of EBC is simple, in most cases
requiring a subject to breathe tidally through a
cooling apparatus via a mouthpiece. Indeed, EBC
using oral tidal breathing has been successfully
collected in children as young as 3 years old.3
However, there have been very few published
methodological studies regarding the collection
and analyses of EBC and there remain a number
of unresolved issues. These include breathing
patterns, reproducibility and dilution of com-
pounds. The aim of this study was to investigate
the repeatability and flow dependence of NOx
in EBC.Methods
Subjects
Twenty-five healthy adults (12 females, age range
23–55 years) and 22 children (11 females, age range
7–16 years) were recruited to participate in various
methodological studies (see below). Of the 22
children, 10 had cystic fibrosis (CF), 4 had asthma
and 8 had no respiratory disease. The studies were
approved by the King Edward Memorial and Princess
Margaret Hospitals Human Ethics Committee. Writ-
ten consent was obtained from all adults and
parents of the children.
Collection of EBC
The collection device was custom made and based
on a method described previously.3 Briefly, subjects
were asked to breathe via a mouthpiece, whichincluded a saliva trap and one-way valve, through a
straight piece of Teflon tubing (length 55 cm, ID
1 cm). The Teflon tubing was encased in polypro-
pylene pipe. Commercially available icepacks were
wrapped around the tube and held in place by the
pipe. Subjects breathed through the apparatus for
between 5 and 10min. The condensate was
collected directly into a 1.5mL microfuge tube
and stored at 80 1C until analysis.
Measurement of nitric oxide metabolites
Total NOx were measured using the Sievers nitric
oxide analyzer (NOA 280, Liquid System, Boulder,
USA). Concentration of NOx was expressed in mmol/
L. Briefly, using a micro-syringe aliquots of 20 or
50 mL of the condensate were instilled into a heated
reaction-cylinder which contained a saturated
solution of Vanadium (III) chloride (VCl3) in 1M
HCl. The NO3 was reduced by the VCl3 to NO2 which
was further reduced to gaseous NO. The NO was
then measured by a rapid response NO-Analyzer
(Sievers, Boulder, USA). The reaction chamber was
cleaned with UHPW before each analysis. Total NOx
levels were calculated from a calibration curve
which ranged from 0.625 to 10 mmol/L. The
calibration curve was linear and considered accep-
table if the r2 was X0.99.
Contamination of collection device
Nitric oxides are found in nearly all environments,
including air, water and lab benches. To determine
if environmental NOx could contaminate the collec-
tion device, known concentrations of NO3 were
nebulised through the tubing. The tubing was
always washed using ultra-high pure water before
these tests, however, 3 of the tubes were allowed
to drip dry while 4 were wiped clean after cleaning
and just prior to use. Considerable contamination
was evident if the tubes were left to drip dry.
Average NOx were 9.4 mmol/L in the solution prior
to nebulisation, 14.5 mmol/L in the solution after
nebulisation and 31.4 mmol/L in the solution col-
lected through the tube. When the tubes were
wiped with a clean cloth prior to collection there
was no evidence of contamination from the tubing.
Average NO3 levels were 5.4, 3.9 and 5.0 mmol/L
prior to nebulisation, post-nebulisation and in the
collected condensate, respectively. For all metho-
dology studies we used a clean cloth to wipe the
inside of the tubing prior to collection.
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Repeatability
Three repeatability studies were conducted.
Uncontrolled flow: Repeatability was assessed
for both back-to back (15min apart) and 24 h
measurements. Condensate was collected from 10
adults for 15min repeatability and 20 adults for
24 h repeatability. Condensate was collected during
normal, uncontrolled tidal breathing.
Controlled tidal flow: Condensate was collected
from 9 adults on 2 occasions 15min apart using
controlled tidal flows. Subjects were asked to
maintain a square wave tidal pattern with a
maximal expiratory flow during tidal breathing of
either 250 or 500mL/s for both collections (which-
ever was the most comfortable). Expiratory flow
was measured by inserting a pneumotachograph
(No. 3719, Hans Rudolp Inc., Kansas City, MO)
between the mouthpiece and the collection appa-
ratus and visual feedback was provided via custom
designed software (Anadat, RHT-Infodat, Montreal
Canada).
Controlled flow and temperature: Two collec-
tions were made from 5 adults 15min apart using
controlled tidal flow, as presented above, and
ensuring the internal temperature of the cooling
apparatus was consistent at the start of each
collection. Temperature of the collection tube
was measured using a thermocouple attached to a
digital thermometer. The temperature of the
collection tube was between 12 and 11 1C at
the start of the collection and between 2 and
4 1C after 10min of breathing.
Analytical variability
Variability in NOx may be due to the analytical
procedure. To test the analytical variability, EBC
was collected from 9 adults during normal, uncon-
trolled tidal breathing. Each sample of EBC was
divided into 2 aliquots, stored at 80 1C and then
analysed separately, in a random order, on the
same day.Table 1 NOx levels for repeat measurements from diffe
Measure 1
(mmol/L)
Me
(mm
Uncontrolled flow 15min 1.82 1.8
Uncontrolled flow 24 h 1.72 1.6
Flow controlled 4.11 3.9
Flow and temp controlled 4.44 3.8
Analytical variability 4.58 4.3
COR, co-efficient of repeatability.Effect of expiratory flow
The effect of expiratory flow on EBC NOx was
measured in both adults (n ¼ 18) and children
(n ¼ 23). Three different expiratory flows were
used for each of the adult subjects and two flows
for each of the children. All subjects were asked to
maintain a consistent breathing pattern with a set
maximum expiratory flow. For adults the 3 flows
were 250, 500, and 750mL/s. For children the
expiratory flows were 250 and 500mL/s. To achieve
this subjects maintained a square breathing pattern
at the desired flow, and real-time feedback was
provided using a computer monitor. For both adults
and children the order of the maximum expiratory
flow was randomised, with 15min between collec-
tions in the same subject.Statistical analyses
For both children and adults NOx levels were log-
normally distributed. Data for repeatability and
analytical variability were analysed using Bland and
Altmann plots.9 Differences in NOx levels collected
at the 3 different flows for adults were analysed
using one-way analysis of variance (ANOVA) with
repeated measures. Child flow NOx data were
analysed using a paired t-test. Repeatability (co-
efficient of repeatability—COR) was determined
using the method described by Chinn.10 All statis-
tics were done using SPSS 11.5 (SPSS Science, Inc.,
Chicago, USA), where appropriate total NOx data
are presented as geometric mean (GM) with 95%
confidence intervals (95%CI).Results
Repeatability
For all repeatability measures the mean difference
between any 2 sets of results are expressed as both
raw data and as percentage difference from therent methodology studies.
asure 2
ol/L)
Difference (%)
(mmol/L)
COR (%) (mmol/L)
1 0.01 (5.5) 1.99 (103.4)
8 0.04 (6.8) 1.71 (118.4)
3 0.18 (7.4) 5.30 (116.9)
7 0.57 (22.4) 2.21 (105.0)
7 0.21 (5.9) 3.01 (58.5)
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Figure 1 Bland and Altmann plot for 24-h repeatability of
NOx levels in EBC.
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Figure 2 Bland and Altmann plot for variability of NOx
resulting from the analytical method. Each sample was
divided into 2 aliquots, stored and then analysed on the
same day.
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P. Franklin et al.126mean in order to allow comparison between the
different tests (Table 1).
Uncontrolled flow: Separate Bland and Altmann
plots were generated for the 15min and 24 h
repeatability. The mean difference between 0 and
15min was 0.01 mmol/L (5.5%) with a COR of
1.71 mmol/L (103.4%) (Table 1). For 24 h measure-
ments the mean difference was 0.04 mmol/L (6.8%)
and COR of 1.99 mmol/L (118.4%) (Fig. 1, Table 1).
Controlled flow: Repeatability was not improved
using controlled flows. The difference between
levels collected 15min apart 7.4% with a COR of
116.9% (Table 1).
Controlled flow and temperature: When both
flow and temperature were controlled for repeat
measures the mean difference was 0.57 mmol/L
(22.4%) and the COR was 2.21 mmol/L (105.0%)
(Table 1).0
250 500 750
Expiratory flow (ml/s)
Figure 3 Total NOx levels at 3 different tidal expiratory
flows for adults.Analytical variability
Two aliquots from the same EBC sample were
collected from 9 subjects, stored and then analysed
on the same day. The group mean difference
between the two aliquots was 0.21 mmol/L (5.9%)
with a COR of 3.01 mmol/L (58.5%) (Table 1).
Agreement was very good for 7 of the 9 repeat
injections (Fig. 2).Flow dependence
Adults: Geometric mean (95%CI) NOx levels for the
3 different flows were 1.80 mmol/L (1.35–
2.41 mmol/L), 1.54 mmol/L (1.14–2.07 mmol/L) and
1.57 mmol/L (1.04–2.36 mmol/L) for 250, 500 and
750mL/s, respectively (Fig. 3). There was no
significant difference between levels measured
for the three flows (P ¼ 0:69). However, in some
cases, there was considerable variation between
NOx levels measured at different flows (Fig. 3). Themean coefficient of variation of levels measured at
the 3 different flows for all subjects was 36.5% and
ranged from 1.4% to 73.2%.
Children: There was no difference in the NOx
levels using 2 separate flows for children (Fig. 4).
Geometric mean levels were 2.92 mmol/L
(2.57–3.31 mmol/L) for expiratory flows of 250mL/
s and 2.81 mmol/L (2.46–3.18 mmol/L) for 500mL/s
(P ¼ 0:76). Again, in some cases, there was marked
variability in levels measured at the different flows
with up to 2.5 times difference between levels. We
investigated if there was greater variability in the
CF compared with the healthy group and, although
numbers in each group were small, this was not
the case.
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Figure 4 Total NOx levels at 2 different tidal expiratory
flows for children.
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In these series of studies we investigated a number
of methodological issues regarding the collection
and analyses of nitric oxide metabolites in exhaled
breath condensates. We have found in EBC col-
lected during tidal breathing, that there was
reasonably poor short-term (15min and 24 h)
repeatability in NOx levels and this was not
improved if expiratory flow was controlled and
temperature of the collection device, at the start
of collection, kept constant. About half of this
variability may be explained by variability in the
analytical technique for measuring NOx. We did not
find any significant differences in NOx levels in
either adults or children when EBC was collected at
different expiratory flows, although there was
considerable within-subject variability.
Nitric oxide metabolites are raised in EBC of
various patient groups.2–8 Differences are at least
1-fold higher in disease groups and often greater
than this, although significant overlap is evident
between patients and healthy subjects. Further,
significant reductions in NO metabolites have been
demonstrated in asthmatics after both treatment
with inhaled steroids11 and high-altitude climate
therapy.12 However, very few studies have reported
the repeatability of NO metabolites in EBC, an
important consideration for the use of these
compounds for intervention studies. Ho et al.7
measured nitrites in 7 healthy subjects on two
occasions 3–8 days apart and reported a 95%confidence interval for the intra-subject variability
of71.12 mmol/L. It is not clear how this related to
mean or median levels measured in this group,
however, median nitrite levels for a larger group
of healthy subjects was only 0.36 mmol/L. Ganas
et al.4 measured total NOx on consecutive days in
healthy and asthmatic subjects. The mean differ-
ence (and standard deviation) for the asthmatics
was 0.07 mmol/L (0.04) and 0.03 mmol/L (0.02) for
the healthy subjects. Again, it was unclear how this
related to the mean values. In our series of
repeatability studies the mean differences be-
tween repeat measures were small—usually less
than 10%—however, there was considerable intra-
subject variability with differences between mea-
sures ranging up to 125%. This variability may not
affect differences between healthy subjects and
patients with respiratory disease if group differ-
ences are large, however, it is an important
consideration for intervention studies when
changes in NOx levels may be relatively small,
e.g. less than 1-fold difference.
One factor that may affect the variability of EBC
constituents is expiratory flow. Breath condensates
are often collected during normal tidal breathing
and expiratory flow is generally not controlled.
However, non-volatile substances, such as NO2 and
NO3, are transported to the condensate in respira-
tory droplets14 and the amount of aerosol formed in
the respiratory tract depends on the velocity of the
passing air as well as the surface tension of the
extracellular surface fluid layer.13 Therefore, ex-
piratory flow may be an important determinant of
EBC constituents and variability in concentrations
may be due to breath to breath variations in the
size and number of respiratory droplets generated.
In this study, however, short-term repeatability
of NOx levels was not improved by controlling
tidal flow.
We also found that there was no difference in
NOx levels, in either adults or children, when EBC
was collected at different flows. Other studies have
investigated the effect of flow on both volatile15
and non-volatile16,17 constituents of EBC with
conflicting results. Schleiss et al.15 reported a
significant flow dependence for H2O2 concentra-
tions during full exhalations ranging from 48 to
140mL s1, while variations in flow had no effect on
aldehyde levels in either adults17 or children.16
Despite the lack of significant difference in mean
NOx levels measured using different expiratory
flows there was considerable variability with regard
to the effect of flow in individuals. The reasons
for this observation are unclear but might be due
to variable dilution of airway condensate. Effros
et al.14 suggest that ‘reference indicators’ are
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EBC constituents, although suitable candidates are
yet to be established.
A significant effect of collection temperature on
NOx concentrations in EBC has been demon-
strated.18 For this study, we used a custom built
device that was designed to be light and portable
and could be used for collecting EBC outside the
laboratory. Commercially available ice packs were
used as the coolant and the temperature of these
may vary depending on time in and out of the
freezer. In a small number of subjects we found
that controlling the initial temperature of the
collection device did not improve the repeatability
of NO metabolites in EBC but it is likely that the
temperature range of the tubes had not varied
greatly during the initial repeatability studies.
Some of the variability in repeated measure-
ments of EBC compounds may be due to variability
in the assay. Indeed, Zacharasiewicz et al.19
recently reported that, for sodium and chloride
concentrations in EBC, the analytical variability
accounted for most of the within day variability.
Further, Van Hoydonck et al.20 found that neither 8-
isoprostane nor hydrogen peroxide levels could be
reproducibly assessed due to low concentrations or
poor sensitivity of the available assays. We inves-
tigated the analytical variability for NOx analyses
using our collection device and analytical method.
This seemed to account for about half of the
variability we had observed although repeatability
of 7 of the 9 paired samples was very good (i.e.
varied by 20% or less). We did not observe such a
high proportion of repeatable results in other
methodology studies.
Nitric oxides are found in most environments and
there is considerable potential for contamination of
the EBC during collection and analyses of samples.
Indeed, we found that if the collection tubing was
not cleaned (wiped) just prior to collection there
was evidence of contamination in the sample. It is
also possible that contamination can occur during
the analyses in simple ways such as touching the
injection needle with your hands. The injection
needle was always flushed with ultra-high pure
water and wiped clean between injections. For all
studies the samples were injected 3 or 4 times but
we only accepted the levels when at least 2 results
varied by less than 5%. However, we did sometimes
see 100% difference between repeat injections
suggesting contamination could easily occur. Con-
siderable care needs to be taken to reduce the
risk of contamination in the collection and analyses
of NOx.
Our results suggest there is an inherent varia-
bility in the repeat measurement of EBC NOx thatcannot be fully explained by the collection or
analytical technique. Day-to-day variability, there-
fore, needs to be taken into consideration if EBC
NOx is to be useful in tracking the progression of
disease or effect of treatment in individual
patients. Variability of other EBC constituents
needs to be investigated fully before EBC can be
used as a reliable clinical tool.References
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